KWR · Quaker Chemical Corp
$165.91
+1.60 (+0.97%)
At close · Aug 28
Market Cap
$2.85B
Shares
17.21M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$165.91
Open$163.57
Day$163.57–171.17
52W close$114.74–180.57
Avg vol 30d152K
Short int1.8M · 10.3% float · 11.0d
Short vol83%
Last earningsJul 31, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 31, 2026
Est · unconfirmed
· in 9 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Moderate
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+13%
above
Price vs 50-day avg
+4%
above
RSI (14)
55
neutral
MACD trend
Negative
52-week position
78%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+3%
trailing
6-month return
+28%
trailing
YTD return
+21%
this year
Relative strength
+15%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $159 › 200d $146 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +57 funds added
Insider flow
Distributing
Net -$101.0K over 90 days · 100% sells
Short interest
Rising
10.35% of float · ▲ +0.2% MoM · 11.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
314 holders — near 3-yr high, broad support
Squeeze score
72
high risk · 0–100
Fundamentals
Revenue growth
+3%
Y/Y
Gross margin
36%
contracting
EPS growth
−102%
Y/Y
Free cash flow
$80.6M
Valuation
P/E 29.7
in line
Buyback
$250.0M
authorized
Balance sheet
$691.4M
net debt
Quant / Vol
risk profile
Volatility
39%
annualized · 1-yr
Max drawdown
−36%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Apr 30, 2026
Annualized cost savings
· by 2028
$20M – $30M
Prior guidance
period ended
· from the Earnings Call filed Jun 30, 2025
Cost savings
· second half of 2025
$5M – $8M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+13%
Bullish
Price vs 50-day avg
+4%
Bullish
RSI (14)
55
Neutral
MACD trend
Negative
Bearish
52-week position
78%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $159 › 200d $146 — 50d above 200d
Institutional flow
Accumulating
+9% holders QoQ · +57 funds added
Insider flow
Distributing
Net -$101.0K over 90 days · 100% sells
Short interest
Rising
10.35% of float · ▲ +0.2% MoM · 11.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
314 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $115
Now $166 · 78%
Range high $181
vs 200-day avg +13%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $85.2M | second quarter of 2026 filing | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP EBITDA $73.48M
-$3.03M Equity income in a captive insurance company (f)
+$0K Acquisition-related step-up inventory amortization (l)
+$8.12M Restructuring and related charges, net (a)
+$219K Acquisition-related expenses (b)
+$0K Gain on inventory and other adjustments (m)
+$4.11M Business transformation costs (c)
+$326K Pension and postretirement benefit costs, non-service components (d)
+$0K Impairment charges (o)
-$1M Product liability claim reimbursement (p)
+$584K Currency conversion impacts of hyper-inflationary economies (g)
+$0K (Gain) loss on acquisition-related hedges (h)
+$0K Gain on sale of assets (i)
+$1.71M Debt modification and extinguishment costs (n)
+$564K Duplicate headquarter lease costs (q)
+$86K Other charges (e)
= Adjusted EBITDA $85.17M
|
|||
| Adjusted EBITDA margin (%) non-GAAP | 15.6% | Six Months Ended June 30, 2026 | — |
|
|
|||
| employees | 4,700 | current | — |
| Non-GAAP earnings per diluted share non-GAAP | $3.82 | Six Months Ended June 30, 2026 | — |
|
|
|||
| Non-GAAP gross margin (%) non-GAAP | 36.1% | Six Months Ended June 30, 2026 | — |
| Non-GAAP gross profit non-GAAP | $189.2M | Three Months Ended June 30, 2026 filing | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Gross profit $189.2M
+$0K Acquisition-related step-up inventory amortization (l)
+$0K Gain on inventory and other adjustments (m)
= Non-GAAP gross profit $189.2M
|
|||
| Non-GAAP net income non-GAAP | $37.9M | the second quarter of 2026 filing | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Adjusted EBITDA $85.17M
-$25.6M Less: Depreciation and amortization (r)
-$9.87M Less: Interest expense
-$13.38M Less: Taxes on income before equity in net income of associated companies - adjusted (s)
+$1.59M Plus: Acquisition-related depreciation and amortization (k)
= Non-GAAP net income $37.9M
|
|||
| Non-GAAP operating income non-GAAP | $55.29M | Three Months Ended June 30, 2026 filing | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Operating income (loss) $40.6M
+$0K Acquisition-related step-up inventory amortization (l)
+$8.12M Restructuring and related charges, net (a)
+$219K Acquisition-related expenses (b)
+$0K Gain on inventory and other adjustments (m)
+$4.11M Business transformation costs (c)
+$0K Impairment charges (o)
+$564K Duplicate headquarter lease costs (q)
+$1.59M Acquisition-related depreciation and amortization (k)
+$86K Other charges (e)
= Non-GAAP operating income $55.29M
|
|||
| Non-GAAP operating margin (%) non-GAAP | 9.9% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Operating Cash Flow | $33M | Q2 2026 YTD 2026 | — |
| Segment operating earnings - Americas | $57.2M | the second quarter of 2026 filing | — |
| Segment operating earnings - Asia/Pacific | $36.6M | the second quarter of 2026 filing | — |
| Segment operating earnings - EMEA | $32.7M | the second quarter of 2026 filing | — |
| trailing twelve months adjusted EBITDA non-GAAP | $312.4M | twelve-month period ended June 30, 2026 | — |
| Cash and cash equivalents | $170M | as of March 31, 2026 | — |
| Net debt | $705M | as of March 31, 2026 | — |
| Q1’26 cost of debt on credit facility | 4.8% | Q1 2026 | — |
| Total debt | $875M | as of March 31, 2026 | — |
| Capital returned to shareholders through dividends and share repurchases | $75.9M | Full Year 2025 | — |
| Share Repurchases | $42M | Q4 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KWR
this stock
Quaker Chemical Corp
|
$2.85B | +20.8% | +2.7% | 29.7 | 10.3% |
|
LIN
Linde PLC
|
$225.65B | +14.8% | +3.0% | 31.6 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.15B | +5.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.55B | +6.4% | +2.1% | 31.8 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.38B | +9.2% | +2.2% | 38.5 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KWR | +1.8% | +3.4% | +28.1% | +3.4% | +20.8% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +1.3% | +0.4% | +14.6% | +0.4% | +8.0% |
Capital returns
Latest dividend
$0.508
/ share · ex Jul 17, 2026
Declared · upcoming
$0.53
/ share · ex Oct 16, 2026
Paid (TTM)
$2.032
/ share · 4 payouts
Dividend yield (TTM, derived)
1.22%
Buyback program
· as of Jul 30, 2026
Authorized
$250.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
81362
CUSIP
747316107
13F (30d)
238 filings
235 filers
Visit website
Investor relations